We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · January 23, 2020

Efficacy of Chemotherapy and Atezolizumab in Patients With NSCLC Receiving Antibiotics and Proton Pump Inhibitors

Annals of Oncology

 

Additional Info

Annals of Oncology
Efficacy of Chemotherapy and Atezolizumab in Patients With Non-Small Cell Lung Cancer Receiving Antibiotics and Proton Pump Inhibitors: Pooled Post-Hoc Analyses of the OAK and POPLAR Trials
Ann. Oncol 2020 Jan 16;[EPub Ahead of Print], M.Chalabi, A Cardona, DR Nagarkar, et al

Further Reading